Tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2 positive breast cancer (TUTOR): Study protocol for a multicenter phase 1 clinical trial

Publication Date

2025

Content Type

article

PubMed ID:

41339822

Additional Authors:

Additional Authors and Institutional Affiliations

This document is currently not available here.

Share

COinS